In addition, STING activation upregulates chemokines such as CXCL9 and CXCL10, thereby promoting T cell infiltration into the tumor microenvironment and further augmenting antitumor immunity (de Mingo Pulido et al., 2021). The gene discussed is STING1; the disease is neoplasm.